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Abstract: Natural marine products have shown an interesting array of diverse and novel 
chemical structures with potent biological activities. Our study reports the antiproliferative 
assays of crude extracts, fraction and pure compound (4R,9S,14S)-4α-acetoxy-9β,14α-
dihydroxydolast-1(15),7-diene (1) obtained from brown alga Canistrocarpus cervicornis 
showing the antileishmanial activity. We showed that 1  had a dose-dependent activity 
during 72 h of treatment, exhibiting IC50 of 2.0 µg/mL, 12.0 µg/mL, and 4.0 µg/mL for 
promastigote, axenic amastigote and intracellular amastigote forms of Leishmania 
amazonensis, respectively. A cytotoxicity assay showed that the action of the isolated 
compound  1  was 93.0 times less toxic to the macrophage than to the protozoan. 
Additionally, compound 1  induced ultrastructural changes, including extensive 
mitochondrial damage; decrease in Rh123 fluorescence, suggesting interference with the 
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mitochondrial membrane potential; and lipid peroxidation in parasite cells. The use of 1 
from C. cervicornis against L. amazonensis parasites might be of great interest as a future 
alternative to the development of new antileishmanial drugs. 
Keywords: antileishmanial activity; Leishmania amazonensis; Canistrocarpus cervicornis 
 
1. Introduction 
Human leishmaniasis is an endemic parasitic disease which represents a major health problem in the 
tropical and subtropical regions of the world. The prevalence is 12 million people and the overall 
population at risk is 350 million people [1]. 
Leishmaniasis is caused by a species of the Leishmania, a flagellated protozoan from the 
Trypanosomatidae family. The disease is transmitted by the bite of a sandfly which belongs to Lutzomia 
genus. Parasites of the Leishmania sp. have a heteroxenic life cycle that includes an intracellular 
amastigote form within the mononuclear phagocytes in mammal hosts and an extracelular 
promastigote form in vector insects [2,3]. 
Leishmaniasis is classified in four distinct clinical forms, visceral (VL), cutaneous (CL), difuse 
cutaneous (DCL) and mucocutaneous leishmaniasis (MCL) [4]. The clinical manifestations depend on 
the parasite species and the susceptibility of the host. The therapy is very complicated because the 
drugs for the treatment have many limitations and Leishmania  species have already presented 
resistence to the drugs [2]. Pentavalent antimonials have been used for leishmaniasis treatment for 
more than 50 years. However, they cause serious side effects, such as cardiac and renal toxicity, as 
well as continuing to require long-term treatment. Other alternative drugs to antimonials in unresponsive 
cases are: Pentamidine and amphotericin B. Unfortunately, these drugs also cause toxic effects [5,6]. 
Bioactive natural products have been isolated from marine organisms and their pharmacological 
properties analyzed [7]. For example, brown algae produce a range of these compounds that have a 
wide variety of ecological functions such as defense against herbivores [8], fouling [9,10] and 
pathogenic microbes [11]. They also display a wide spectrum of pharmacological properties, such as 
antiviral [12], antiprotozoa [13,14], antibacterial [15], antioxidant [16] and anticoagulant [17]. 
A variety of different dolastane and seco-dolastanes diterpenes have been isolated from the   
brown marine macroalga Canistrocarpus cervicornis (formerly  Dictyota cervicornis) [10,18–21].  
In this study the leishmanicidal activity of crude extracts, fraction, and a 4-acetoxy-dolastane  
diterpene (1) obtained from C. cervicornis  were first measured  in laboratory assays against the 
Leishmania amazonensis. 
2. Results and Discussion 
Marine brown algae of the family Dictyotaceae  are rich sources of monocyclic, bicyclic, and 
tryciclic diterpenes as major secondary metabolites [18,22–26]. Interestingly, this seaweed has a wide 
distribution along the Brazilian coast [25]. This traditional medicine still plays an important role in 
primary health care [27]. Plant-derived drugs remain an important resource, especially in developing Mar. Drugs 2011, 9  
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countries, in combating diseases [6]. This is particularly true for marine natural products, which show 
an interesting array of diverse and novel chemical structures with potent biological activities [28]. 
Our study reports the antiproliferative assays of crude extracts (EACE, MCE and DCE), fraction 
(EAF) and pure compound (1) (4R,9S,14S)-4α-acetoxy-9β,14α-dihydroxydolast-1(15),7-diene 
(Figure 1) obtained from brown alga C. cervicornis  showing the dose-dependent effect against 
promastigote forms of L. amazonensis (Figures 2 and 3). In Table 1, we have demonstrated the 
concentrations values of crude extracts, fraction, and 1 that inhibited 50% of this parasite (IC50 values) 
after 72 h of incubation. Thus, the IC50 of crude extracts EACE, MCE and DCE were 50.0 µg/mL, 
100.0 µg/mL and 20.0 µg/mL, respectively. The IC50 of fraction (EAF) and 1 were 8.0 µg/mL and  
2.0 µg/mL, respectively. The student’s t test (p < 0.05) indicated significant differences between crude 
extracts, fraction and isolated compounds compared to the control group. In addition, amphotericin B 
showed IC50 of 0.06 µg/mL against promastigote forms after 72 h of treatment.  
Figure 1.  Chemical structure of compound 1  (4R,9S,14S)-4α-acetoxy-9β,14α-dihydro 
xydolast-1(15),7-diene, isolated from Canistrocarpus cervicornis. 
 
Figure 2. Effect of crude extracts (EACE, MCE and DCE), and fraction (EAF) from brown 
alga  Canistrocarpus cervicornis  against promastigote forms of Leishmania amazonensis. 
Each bar represents one standard deviation. 
 Mar. Drugs 2011, 9  
 
 
2372 
Figure 3. Effect of compound  1  from brown alga Canistrocarpus cervicornis  against 
promastigote (♦), and axenic amastigote (●) forms of Leishmania amazonensis. Each bar 
represents one standard deviation. 
 
Table 1.  Comparison between values of CC50  for J774G8 macrophages and IC50  for 
promastigote forms of Leishmania amazonensis, and their respective selectivity indexes (SI). 
Compound  CC50 (µg/mL) 
a 
Promastigote forms 
IC50 (µg/mL)  SI 
EACE  50.0 ± 0.08  50.0 ± 2.12  1.00 
MCE  51.0 ± 0.20  100.0 ± 4.50  0.51 
DCE  46.0 ± 0.46  20.0 ± 1.55  2.30 
EAF  47.0 ± 0.75  8.0 ± 0.55  5.88 
1 
Amphotericin-B 
186.0 ± 3.29 
nd 
2.0 ± 0.37 
0.06 ± 0.00 
93.00 
nd 
Values represent the mean ± S.D. of at least three experiments performed in triplicate. 
a  On 
macrophage strain J774G8 at 48 h of culture. SI = CC50 J774G8/IC50. nd: not determined. 
The cytotoxicity on macrophage strain J774G8 of crude extracts, fraction, and isolated compound 
were also evaluated (Table 1). When macrophages were treated with crude extracts EACE, MCE, and 
DCE the 50% cytotoxic concentration (CC50) were 50.0 µg/mL, 51.0 µg/mL, and 46.0 µg/mL, 
respectively. The CC50  of fraction (EAF) was 47.0 µg/mL and CC50  of  1  was 186.0 µg/mL.   
The cytotoxicity to the macrophage and the activity against the protozoan were compared by using the 
selectivity index (SI). The better results of SI for promastigote forms were obtained with fraction EAF 
(SI = 5.88) and isolated compound 1 (SI = 93.0). So, EAF and 1 were respectively 5.88 and 93.0 times 
less toxic to the macrophage than to the protozoan. 
The pure compound 1 was more active than crude extracts and fraction. Thus, further experiments 
were carried out using only this compound. Isolated compound 1 had the activity investigated against 
axenic amastigote forms of L. amazonensis (Figure 3). The IC50 obtained value was 12.0 µg/mL. The 
effect of the 1  on intracellular amastigotes was observed during 24 h of incubation (Figure 4). 
Treatment of intracellular amastigotes with 5.0, 15.0, and 30.0 µg/mL with 1 resulted in decreases in 
the survival index of 56.0, 72.0, and 76.0%, respectively, compared to the control. Additionally, the 
IC50 was 4.0 µg/mL. These results were significant at p ≤ 0.05 as compared to the control group, by the Mar. Drugs 2011, 9  
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student’s t test. In this regard, the result of this preliminary study is very encouraging because it is the 
amastigote forms of Leishmania that persist in the human host and directly cause all of the clinical 
manifestations of leishmaniasis [29]. Amphotericin B showed IC50 of 0.25 and 0.35 µg/mL against 
axenic amastigote and intracellular amastigote forms, respectively. 
Figure 4. Survival index of Leishmania amazonensis within peritoneal macrophage cells 
treated with compound  1. (1) Untreated control; (2) Treated with 1  at 5.0 µg/mL;  
(3) Treated with 1 at 15.0 µg/mL; (4) Treated with 1 at 30.0 µg/mL. Each bar represents 
the mean ± standard error of at least three independent experiments, which were performed 
in duplicate. * Significant difference of each group from the control (p < 0.05). 
 
To find cellular targets in leishmania cells treated with 1, TEM and flow cytometry techniques were 
employed. We verified that 1 produced ultrastructural alterations in L. amazonensis. Figure 5 shows 
transmission electron microscopy photomicrographs of promastigotes treated with the isolated 
compound  1. Figure 5A shows untreated cells with a terminal flagellum, nucleus, and the single 
mitochondrion with a branched structure,  characteristic of this group of organisms, containing a   
disk-shaped aggregate of DNA called a kinetoplast. In L. amazonensis treated with 1, we highlight that 
the main alteration which occurred in the mitochondria of the parasite, was seen as intense 
mitochondrial swelling, as seen in Figure 5B–F. 
In accordance with these findings, tests using specific markers for mitochondria were performed. 
Data obtained from a flow cytometry by using Rh123 presented in Figure 6 showed a marked decrease 
in the percentage population of upper right gate (76.55% and 68.71%). This indicates depolarization of 
the mitochondrial membrane potential in the cells following treatment with 1  at 50 µg/mL and   
100 µg/mL, respectively (Figure 6). Similarly, a decrease in membrane potentials was also observed 
following treatment with the standard drug Carbonyl Cyanide m-chlorophenylhydrazone (CCCP) 
(75.37%) at 200 µM for 3 h at 32 °C. In contrast, untreated cells maintained the membrane potential 
(98.41%) (Figure 6, upper right quadrant). The student’s t  test (p  < 0.05) indicated significant 
differences between cells treated with copaiba oil compared to the negative control group. Mar. Drugs 2011, 9  
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Figure 5.  Ultrastructural effect of compound 1  after incubation for 72 h at 25 °C on 
promastigotes forms of Leishmania amazonensis observed by Transmission Electron 
Microscopy. (A) Promastigote Control; (B  and  C) Promastigote forms treated with   
2 µg/mL of 1; (D to F) Promastigote forms treated with 10 µg/mL of 1. The treatment led 
to notable swollen mitochondrial (black stars). n, nucleus; f, flagellum; fp, flagellar pocket; 
k, kinetoplast; m, mitochondrion. Bars = 1 µm. 
 Mar. Drugs 2011, 9  
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Figure 6. Flow cytometry analysis of Rh123-labeled axenic amastigotes of Leishmania 
amazonensis. Compound 1 collapsed the ΔΨm, leading to parasite death. (A) Untreated 
cells; (B) CCCP 200 µM; (C) Amastigotes treated with 50 µg/mL; (D) Amastigotes treated 
with 100 µg/mL. The bold numbers represent the percentage of the collapsed ΔΨm cells in 
the upper right quadrant. 
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Mitochondrion found in trypanosomatid parasites had distinct structural and functional 
characteristics of mammalian cells making this organelle an exceptionally attractive chemotherapeutic 
target. Likewise, investigations have shown that mitochondria can be targeted by different drugs for 
Leishmania sp. [13,14,30–32]. Additionally, several studies have reported that mitochondrial alterations 
may lead to programmed cell death by apoptosis [33–36]. 
In order to evaluate the effects of the compound 1, the lipid peroxidation of cell membrane was 
determined. It was assessed by measuring TBARS in leishmanial cells after treatment with 1 compared 
to control or untreated cells (Figure 7). In addition, thenoyltrifluoroacetone (TTFA), a conventional 
mitochondrial complex II inhibitor, was used as positive control. Compound 1 treatment at 100 µg/mL 
displayed an increase in lipid peroxides after 6 h of drug treatment, with a 3.4-fold lipoperoxidation 
compared to the untreated control cells while the increase in lipid peroxidation obtained with the 
TTFA was 2.1-fold compared to the control. Previous studies have demonstrated that loss of the 
mitochondrial membrane potentially induces formation of reactive oxygen species (ROS) inside cells, 
which induces lipid peroxidation. Moreover, the cellular ROS generation in turn leads to the damage of 
the oxidative citoplasmatic membrane, and DNA lesions [33,34,37,38].  
Figure 7. Effect of compound 1 on lipid peroxidation (production of malondialdehyde 
(MDA)) of amastigote forms of Leishmania amazonensis. Each bar represents the   
mean ± standard error of at least three independent experiments, which were performed in 
duplicate. * Significant difference of each group from the control (p < 0.05). 
 
3. Experimental Section 
3.1. Algal Collection 
Specimens of the brown macroalga C. cervicornis (Dictyotaceae, Phaeophyta) were collected by 
free diving off the coast of Paraíso Beach, Pernambuco State, Brazil (08°21′S, 34°57′W), in October 
2009, at depths between 1 and 2 m. The algal material was cleaned manually from epiphytic organisms 
and air-dried immediately after collection. Voucher specimens were deposited in the Herbarium of 
Universidade Federal de Pernambuco, Recife, Brazil (62948). Mar. Drugs 2011, 9  
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3.2. Chemical Extraction 
The air-dried algal material (300.0 g of C. cervicornis) was extracted in dichloromethane (CH2Cl2) 
at room temperature for 30 days and the solvent was evaporated in vacuo by rota-evaporation, yielding 
14.6 g of dry dichloromethane crude extract (DCE). The residue was further extracted in ethyl acetate 
(EtOAc) using similar procedures, yielding 0.9 g of dry ethyl acetate crude extract (EACE), and finally 
extracted in methanol (MeOH), yielding 0.3 g of dry methanol crude extract (MCE). 
3.3. Fractionation and Compound Isolation 
A part of DCE (5 g) was subjected to silica gel 70–230 mesh column chromatography (3.5 × 25 cm), 
eluted with n-hexane, CH2Cl2, EtOAc, Me2CO, and MeOH in sequence, to give 45 fractions of 20 mL 
each one (F1–F45). The fractions F12–F25 eluted with CH2Cl2 showed similar when analyzed by TLC 
and it were combined to produce a dark brown-green residue (1.2 g), which was subjected to new silica 
gel 70–230 mesh column chromatography (2 × 25 cm) eluted with n-hexane/EtOAc (3:1) increasing 
the polarity until 100% AcOEt, to give 48 fractions (F1–F48, 10 mL each one). The fractions F14–F18 
were analyzed by TLC and showed intense browns spots (Rf = 0.47, mobile phase n-hexane/EtOAc 3:1), 
then it was combined (200 mg). Following this, fractions were subjected to new silica gel 70–230 mesh 
column chromatography (1.0 × 20 cm), eluted with n-hexane/EtOAc (4:1), to give 20 fractions (F1–F20). 
The Fraction F8 afforded the pure compound (4R,9S,14S)-4α-acetoxy-9β,14α-dihydroxydolast-1(15), 
7-diene (1) (143.0 mg, yellow gum). 
The fractions F26–F38 eluted with EtOAc from DCE showed similar results when analyzed by 
TLC, and then they were combined to produce a brownish residue (1.3 g) which was named EAF 
(ethyl acetate fraction). 
All the crude extracts formed (EACE, DCE, and MCE), fraction (EAF) and pure compound isolated 1 
were monitored by TLC using silica gel GF254 (Merck) as stationary phase and n-hexane/EtOAc 3:1 
and 4:1 as mobile phase. The chromatoplates used were revealed through spraying it with a solution of 
ceric sulphate and sulfuric acid acquired by 2.1 g of Ce2(SO4)3.4H2O; 21 mL of H2SO4 and 300 mL of 
H2O, followed by heating at 100 °C for 3 min. 
3.4. Spectroscopic Data 
The physical and spectroscopic properties of the diterpene (4R,9S,14S)-4α-acetoxy-9β,14α-dihydro 
xydolast-1(15),7-diene (143.0 mg, yellowish gum) were found to be identical with the previously 
reported data [39]. 
3.5. Parasites 
Leishmania promastigotes were grown in Warren’s medium (brain-heart infusion plus hemin and 
folic acid) pH 7.2, supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco Invitrogen 
Corporation, New York, USA), at 24 °C in a tissue flack. The strain used was Leishmania amazonensis 
(MHOM/BR/Josefa) originally isolated from a human case of difuse cutaneous leishmaniasis.  Mar. Drugs 2011, 9  
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Leishmania  axenic amastigotes were obtained by  in vitro  transformation of infective   
promastigotes [40]. These forms were maintained in Schneider’s medium (Sigma, St. Louis, MO, 
USA) pH 4.6, supplemented with 20% heat-inactivated FBS, at 32 °C in a tissue flask. 
3.6. Macrophage J774G8 Cells 
Murine macrophage J774G8 cells were maintained in tissue flasks composed of RPMI 1640 
medium (Gibco Invitrogen Corporation, New York, USA), sodium bicarbonate, L-glutamine, and 
supplemented with 10% heat-inactivated FBS in a 5% CO2–air-mixture. 
3.7. Antileishmania Activity in Vitro against Promastigotes and Axenic Amastigotes 
The growth inhibition test that was performed on promastigotes forms of L. amazonensis from a  
48 h logarithmic phase culture was suspended to yield 1 × 10
6 parasites/mL. It was then cultivated in 
24-well culture plates at 25 °C in Warren’s medium, supplemented with 10% FBS in the presence or 
absence of increasing concentration of 1  for 72 h. In a same way, axenic amastigotes forms of 
L. amazonensis from 72-h-old logarithmic-phase culture were suspended to yield 1 × 10
6 parasites/mL, 
and then were cultivated in 12-well culture plates at 32 °C in Schneider’s medium. Next they were 
supplemented with 20% FBS in the presence or absence of increasing concentration of compound 1 for 
72 h. Amphotericin was used as a positive control. DMSO was used for the solubilized drugs, but the 
final DMSO concentration did not exceed 0.5%, which did not show deleterious effects on the 
parasites. The leishmanicidal activity was determined by direct counting of the cells in a Neubauer 
chamber and the 50% inhibition concentration (IC50) was obtained graphically by plotting concentration 
versus percentage of growth inhibition. 
3.8. Activity against Intracellular Amastigotes 
For assay of the effects of the compound on intracellular amastigotes, peritoneal macrophages of 
BALB/C, mice were used. Peritoneal macrophages (5 × 10
5  cells/mL) were plated on coverslips 
(diameter 13 mm) in 24 well plate in RPMI 1640 medium supplemented with 10% inactive FBS, and 
incubated for 24 h at 37 °C in a 5% CO2 atmosphere for adherence, after the peritoneal macrophages 
were infected with promastigotes of L. amazonensis in multiples of 10 parasites per host cell and 
incubated at 37 °C in a 5% CO2 atmosphere. After 6 h of infection, infected macrophages were treated 
with compound in concentrations 10, 20 and 30 µg/mL and incubated 24 h again. Afterwards the 
monolayer’s were washed with PBS, fixed with methanol, and stained with Giemsa. The percentage of 
infected macrophages and the mean numbers of amastigotes/infected macrophage were determined by 
counting at least 200 macrophages in duplicate cultures, and results were expressed as shown in the 
survival index. The survival index was obtained by multiplying the percentage of macrophages cells 
with parasites by the mean number of internalized parasites per cell. 
3.9. Cytotoxicity Assay 
The cytotoxicity assay was performed in 96-well plates. A suspension of 5 × 10
5 J774G8 cells in 
RPMI 1640 medium supplemented with 10% FBS was added to each well in 96-well microtiter plates. Mar. Drugs 2011, 9  
 
 
2379 
The plates were incubated in a 5% CO2–air mixture at 37 °C to obtain confluent growth of the cells. 
After  24 h, the medium was removed and the cells were treated with several concentrations of 
compounds and the plates were incubated for 48 h. Control cells without compound were included. 
The adhered macrophages were fixed with 50 μL/well of 10% trichloroacetic acid at 4 °C for 1 h; after 
that,  the  well  plates  were  washed  with  water,  and  attained  with  50  μL/well  of  sulforhodamine  B 
(0.4% w/v) in 1% acetic acid solution; the microplate was then maintained at 4 °C for 30 min. Next, 
the microplate was washed five times with 1% acetic acid to remove the sulforhodamine B, then  
150 μL/well of 10 mM unbuffered Tris-base solution (Sigma) was added. The absorbance of each 
individual well was read at 530 nm. Dose-response curves were plotted (values expressed as 
percentage of control optical density) and the 50% cytotoxicity concentration (CC50) was determined 
by logarithm regression analysis of the data obtained. 
3.10. Transmission Electron Microscopy 
Ultrastructural analysis was performed on promastigote forms of L. amazonensis  treated with 
2.0 and 10.0 µg/mL of the compound 1, after 48 h for treatment, the parasites were washed in 0.1 M 
phosphate-buffered saline and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at 4 °C. 
The cells were post fixed in a solution containing 1% osmium tetroxide, 0.8% potassium ferrocyanide, 
and 5 mM calcium chloride in 0.1 M cacodylate buffer. Next they were washed in the same buffer, 
dehydrated in increasing concentrations of acetone and embedded in Epon resin. Ultrathin sections 
obtained in an ultramicrotome were stained with uranyl acetate and lead citrate and examined in a 
Zeiss 900 transmission electron microscope. 
3.11. Flow Cytometry 
The  L. amazonensis  axenic amastigotes (5 × 10
6  parasites/mL)  were treated with 1  (50, and  
100 µg/mL for 3 h at 32 °C), or untreated were harvested and washed with PBS. To gain analyses of 
mitochondrial  membrane  potential,  (ΔΨm)  parasites  were  stained  with  Rhodamine  123  (Rh  123)  
(5 mg/mL for 30 min at 37 °C) reagent following the protocol of  manufacturer. The mean of 
fluorescence intensity of the cells was analyzed by flow cytometry FACSCalibur and CellQuest 
software). A total of 10,000 events were acquired in the region previously established as that 
corresponding to the parasites. 
3.12. Measurement of Lipid Peroxidation Product 
Samples of axenic amastigotes in exponential phase, were treated with 100 µg/mL of compound 1 
for 6 h, at 32 °C. The thenoyltrifluoroacetone (TTFA) was used as positive control. After treatment, 
cells were washed with phosphate buffer, homogenized and added to a solution of 0.37% thiobarbituric 
acid in 15% trichloroacetic acid and 0.25 N HCl. The mixture was heated at 90–95 °C for 45 min. 
After cooling, butanol (1:1) was added to the solution. The mixture was shaken and centrifuged at 
2000× g during 5 min. The optical density of the organic layer was determined at 535 nm in BIO-TEK 
Power Wave XS spectrophotometer. Lipid peroxidation was determined by the generation of Mar. Drugs 2011, 9  
 
 
2380 
thiobarbituric acid-reactive substances (TBARS) in terms of malondialdehyde (MDA), expressed in 
MDA nmol × protein mg
−1 [41]. 
3.13. Statistical Analysis 
All experiments were performed in duplicate. The means and standard deviations were determined 
from at least three experiments. Statistical analysis was performed with the program GraphPad Prism 4 
(GraphPad Software, San Diego, California, USA). The student’s t test was applied, and a p value less 
than 0.05 were regarded as significant. 
4. Conclusions 
New antileishmanials from natural products are urgently needed due to the emergence of drug 
resistance in patients. In this context, the use of the compound 1  isolated from C. cervicornis  
against  L. amazonensis  parasites is of great interest. The  in vitro  treatment of the parasites with 
compound 1 showed notable ultra structural changes, displayed depolarization in the mitochondrial 
membrane potential, and an increase of lipid peroxidation. Although the mechanism of action of the 
compound 1 is still unclear, these findings appear to be a future alternative to development of new 
antileishmanial drugs. 
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